265 reports of this reaction
3.7% of all CINACALCET reports
#4 most reported adverse reaction
HYPOCALCAEMIA is the #4 most commonly reported adverse reaction for CINACALCET, manufactured by Amneal Pharmaceuticals LLC. There are 265 FDA adverse event reports linking CINACALCET to HYPOCALCAEMIA. This represents approximately 3.7% of all 7,231 adverse event reports for this drug.
Patients taking CINACALCET who experience hypocalcaemia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOCALCAEMIA is moderately reported among CINACALCET users, representing a notable but not dominant share of adverse events.
In addition to hypocalcaemia, the following adverse reactions have been reported for CINACALCET:
The following drugs have also been linked to hypocalcaemia in FDA adverse event reports:
HYPOCALCAEMIA has been reported as an adverse event in 265 FDA reports for CINACALCET. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOCALCAEMIA accounts for approximately 3.7% of all adverse event reports for CINACALCET, making it a notable side effect.
If you experience hypocalcaemia while taking CINACALCET, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.